{
  "id": 9617584,
  "title": "JNC Targets Bigger Molecules with Cellufine",
  "url": "https://urgent.news/2026/09/24/jnc-targets-bigger-molecules-with-cellufine",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T19:48:59.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/bioprocessing/jnc-targets-bigger-molecules-with-cellufine/"
  },
  "original_language": "en",
  "account": "JNC is tackling the issue of larger molecules and particles in biopharmaceutical purification at BioProcess International 2026. The company is showcasing its Cellufine chromatography portfolio, which includes monolith-like particle (MLP) products being developed. Cellufine is a family of cellulose-based chromatography media for purifying biopharmaceuticals. MLP products use a large-pore bead architecture to improve access for bulky biological targets that are difficult to accommodate with conventional porous media. JNC is highlighting two development-stage MLP products through poster presentations: Cellufine MLP DexQ for separating AAV particles and Cellufine MLP DexS for viral-vector purification. Tests have shown that MLP DexS can concentrate inactivated influenza virus 13-fold while reducing protein impurities by 90.3%. For other tests, it achieved a 97.3% reduction in protein impurities and 91% virus recovery. JNC's showcase at BPI26 aims to demonstrate how chromatography can evolve to accommodate therapeutic modalities of various sizes.",
  "summary": "JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, vaccines, and other increasingly large and complex biological products. The post JNC Targets Bigger Molecules with Cellufine appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [
    "JNC presents Cellufine chromatography portfolio at BioProcess International 2026",
    "MLP products use large-pore bead architecture for bulky biological targets"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}